India just became the third nation with a private company in orbit: Skyroot's 3D-printed Vikram-1 hit 450 km LEO, backed by a $1.1B valuation.
DeepSeek, the Chinese lab that wiped ~$600B off Nvidia in a day, is raising up to $7B at a $74 billion valuation ahead of an onshore IPO.
Stripe never went public — now it and Advent International are bidding $53 billion ($60.50/share, a 28% premium) to take PayPal private. The real prize: Venmo.
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Helsing just closed a $1.8B Series E at an $18B valuation — Europe's biggest-ever defense-startup round, and the cap table was oversubscribed.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
